Key result
Nebulized salbutamol preserves normal sinus rhythm in healthy cats with a modest ~14-bpm heart rate increase.
Why the study?
Early theoretical concerns about beta-1 cross-reactivity in felines motivated this evaluation of the physiological, electrocardiographic, and echocardiographic effects and cardiovascular safety of nebulized salbutamol in healthy cats.
Does nebulized salbutamol affect physiological, electrocardiographic, and echocardiographic cardiovascular safety variables in healthy adult cats?
Does nebulized salbutamol affect physiological, electrocardiographic, and echocardiographic cardiovascular safety variables in healthy adult cats?
In healthy adult cats, a standard therapeutic dose of nebulized salbutamol demonstrates a high margin of acute cardiovascular safety, preserving normal sinus rhythm and systolic function with only mild, physiologically expected increases in heart rate and E/A ratio.
Answers are grounded in this paper and cite their sources.
Supports acute cardiovascular safety in healthy cats; leaves open translation to diseased models and clinical practice.
min. The E-wave/A-wave ratio increased from 2.44 ± 0.33 to 3.05 ± 0.56. Normal sinus rhythm was maintained in all subjects (100%). Sinus tachycardia was observed in 65.00% of cats, transient PR interval shortening in 25.00%, and isolated premature atrial contractions in 15.00%. No pathological arrhythmias or significant conduction blocks were detected. Respiratory rate showed a minor increase from 38.05 ± 5.87 to 40.05 ± 5.96 breaths/min, while blood pressure and body temperature remained stable. Nebulized salbutamol demonstrates a high margin of cardiovascular safety in healthy cats. The preservation of normal sinus rhythm and clinically insignificant nature of the observed physiological changes support its continued use as a first-line bronchodilator in feline respiratory medicine.
No takes yet. Share an insight, caveat, or question.
Azadi et al. (2026) studied Healthy cats (evaluating cardiovascular safety for feline asthma) (n=20). Nebulized salbutamol vs. Pre-treatment baseline (within-subject control) was evaluated on Heart rate (beats per min) (Cohen's d ~0.50, p=0.03). Nebulized salbutamol preserved normal sinus rhythm in 100% of healthy cats while causing modest, clinically insignificant increases in heart rate and E/A ratio.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: